Similar articles

• [Ethical problems of the clinical placebo use].

  Engelhardt K. Engelhardt K. Dtsch Med Wochenschr. 2004 Sep 10;129(37):1939-42. doi: 10.1055/s-2004-831367. Dtsch Med Wochenschr. 2004. PMID: 15372375 German. No abstract available.
• Pseudo cluster randomization dealt with selection bias and contamination in clinical trials.

  Teerenstra S, Melis RJ, Peer PG, Borm GF. Teerenstra S, et al. J Clin Epidemiol. 2006 Apr;59(4):381-6. doi: 10.1016/j.jclinepi.2005.10.003. Epub 2006 Feb 14. J Clin Epidemiol. 2006. PMID: 16549260 Review.
• Evaluation of randomized controlled trials.

  Stanley K. Stanley K. Circulation. 2007 Apr 3;115(13):1819-22. doi: 10.1161/CIRCULATIONAHA.106.618603. Circulation. 2007. PMID: 17404173 Review. No abstract available.
• Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

  Woods SW, Gueorguieva RV, Baker CB, Makuch RW. Woods SW, et al. Arch Gen Psychiatry. 2005 Sep;62(9):961-70. doi: 10.1001/archpsyc.62.9.961. Arch Gen Psychiatry. 2005. PMID: 16143728 Review.
• Considering race/ethnicity and socio-economic status in randomized controlled trials. A commentary on Frampton et al.'s systematic review generalizing trial findings and tackling health disparities in asthma research.

  Kreatsoulas C, Anand S. Kreatsoulas C, et al. Soc Sci Med. 2009 Oct;69(8):1155-6. doi: 10.1016/j.socscimed.2009.06.019. Epub 2009 Jul 27. Soc Sci Med. 2009. PMID: 19640625 No abstract available.